dr. brufsky on challenges facing biosimilars in breast cancer
Published 6 years ago • 83 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:06
dr. brufsky on challenges in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
5:56
the complexity of choosing biosimilars in oncology
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
9:26
the future direction of biosimilars
-
3:38
biosimilar trastuzumab
-
1:25
dr. brufsky addresses biosimilar skepticism
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology